These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 36778118

  • 1. G protein inhibitory α subunit 2 is a molecular oncotarget of human glioma.
    Wang Y, Liu F, Wu J, Zhang MQ, Chai JL, Cao C.
    Int J Biol Sci; 2023; 19(3):865-879. PubMed ID: 36778118
    [Abstract] [Full Text] [Related]

  • 2. Identification of G protein subunit alpha i2 as a promising therapeutic target of hepatocellular carcinoma.
    Chen M, Li Z, Gu C, Zheng H, Chen Y, Cheng L.
    Cell Death Dis; 2023 Feb 20; 14(2):143. PubMed ID: 36805440
    [Abstract] [Full Text] [Related]

  • 3. Origin recognition complex 6 overexpression promotes growth of glioma cells.
    Yang WL, Zhang WF, Wang Y, Lou Y, Cai Y, Zhu J.
    Cell Death Dis; 2024 Jul 06; 15(7):485. PubMed ID: 38971772
    [Abstract] [Full Text] [Related]

  • 4. Overexpressed Gαi1 exerts pro-tumorigenic activity in nasopharyngeal carcinoma.
    Yin DP, Zhang H, Teng H, Zhang D, Chen P, Xie L, Liu JS.
    Cell Death Dis; 2023 Dec 04; 14(12):792. PubMed ID: 38049415
    [Abstract] [Full Text] [Related]

  • 5. TIMM44 is a potential therapeutic target of human glioma.
    Guo YZ, Chen G, Huang M, Wang Y, Liu YY, Jiang Q, Cao C, Liu F.
    Theranostics; 2022 Dec 04; 12(17):7586-7602. PubMed ID: 36438483
    [Abstract] [Full Text] [Related]

  • 6. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer.
    Jiang JZ, Qiao YB, Zhu XR, Gu QH, Lu JJ, Ye ZY, Xu L, Liu YY.
    Cell Death Dis; 2024 Sep 30; 15(9):699. PubMed ID: 39349432
    [Abstract] [Full Text] [Related]

  • 7. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer.
    Peng SQ, Zhu XR, Zhao MZ, Zhang YF, Wang AR, Chen MB, Ye ZY.
    Cell Death Dis; 2023 Feb 24; 14(2):157. PubMed ID: 36828810
    [Abstract] [Full Text] [Related]

  • 8. Lnc-THOR silencing inhibits human glioma cell survival by activating MAGEA6-AMPK signaling.
    Xue J, Zhong S, Sun BM, Sun QF, Hu LY, Pan SJ.
    Cell Death Dis; 2019 Nov 14; 10(11):866. PubMed ID: 31727877
    [Abstract] [Full Text] [Related]

  • 9. G protein subunit alpha i2's pivotal role in angiogenesis.
    Bai CW, Lu L, Zhang JN, Zhou C, Ni YC, Li KR, Yao J, Zhou XZ, Lan CG, Cao C.
    Theranostics; 2024 Nov 14; 14(5):2190-2209. PubMed ID: 38505600
    [Abstract] [Full Text] [Related]

  • 10. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545.
    Zhang X, Yang H, Zhao L, Li G, Duan Y.
    Cell Death Dis; 2019 Aug 13; 10(8):616. PubMed ID: 31409777
    [Abstract] [Full Text] [Related]

  • 11. G against Glioma: G protein inhibitory α subunit 2 (Gαi2) as a novel glioma target.
    Markopoulos GS.
    Int J Biol Sci; 2023 Aug 13; 19(3):1007-1008. PubMed ID: 36778125
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of CDC2/CyclinB1 in gliomas, and CDC2 depletion inhibits proliferation of human glioma cells in vitro and in vivo.
    Chen H, Huang Q, Dong J, Zhai DZ, Wang AD, Lan Q.
    BMC Cancer; 2008 Jan 29; 8():29. PubMed ID: 18230152
    [Abstract] [Full Text] [Related]

  • 13. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM, Lee DW, Jung JU, Sitcheran R.
    Mol Cancer; 2015 Jan 27; 14(1):9. PubMed ID: 25622756
    [Abstract] [Full Text] [Related]

  • 14. The mitochondrial protein YME1 Like 1 is important for non-small cell lung cancer cell growth.
    Xia Y, He C, Hu Z, Wu Z, Hui Y, Liu YY, Mu C, Zha J.
    Int J Biol Sci; 2023 Jan 27; 19(6):1778-1790. PubMed ID: 37063426
    [Abstract] [Full Text] [Related]

  • 15. Identification of Gαi3 as a novel molecular therapeutic target of cervical cancer.
    Zhang J, Yin DP, Zhang Y, Zhang JN, Yang Y, Zhang ZQ, Zhou L, Lv Y, Huang HW, Cao C.
    Int J Biol Sci; 2022 Jan 27; 18(15):5667-5680. PubMed ID: 36263185
    [Abstract] [Full Text] [Related]

  • 16. ADCK1 is a potential therapeutic target of osteosarcoma.
    Zhuo BB, Zhu LQ, Yao C, Wang XH, Li SX, Wang R, Li Y, Ling ZY.
    Cell Death Dis; 2022 Nov 12; 13(11):954. PubMed ID: 36371387
    [Abstract] [Full Text] [Related]

  • 17. RNA interference-mediated silencing of focal adhesion kinase inhibits growth of human malignant glioma xenograft in nude mice.
    Wang GJ, Ma YP, Yang Y, Zhang N, Wang W, Liu SY, Chen LJ, Jiang Y, Zhao X, Wei YQ, Deng HX.
    Cell Biol Int; 2011 Aug 12; 35(8):841-8. PubMed ID: 21247411
    [Abstract] [Full Text] [Related]

  • 18. Endothelial cell-specific molecule 1 drives cervical cancer progression.
    Lu J, Liu Q, Zhu L, Liu Y, Zhu X, Peng S, Chen M, Li P.
    Cell Death Dis; 2022 Dec 15; 13(12):1043. PubMed ID: 36522312
    [Abstract] [Full Text] [Related]

  • 19. The sodium/myo-inositol co-transporter SLC5A3 promotes non-small cell lung cancer cell growth.
    Cui Z, Mu C, Wu Z, Pan S, Cheng Z, Zhang ZQ, Zhao J, Xu C.
    Cell Death Dis; 2022 Jun 27; 13(6):569. PubMed ID: 35760803
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
    Jutooru I, Chadalapaka G, Lei P, Safe S.
    J Biol Chem; 2010 Aug 13; 285(33):25332-44. PubMed ID: 20538607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.